CHD1L and renal cell carcinoma: Based on the Ruijin-RCC dataset, Kruskal–Wallis (K–W) test analysis further confirmed that CHD1L expressions correlated positively with advanced clinicopathological stages, tumor grades, T stages, as well as metastatic status (Fig. 1E).